None listed
Conditions
Interventions
Intervention1: Vivel Deodorant Aerosol Spray B.No. 60180: Baseline, 2hr,4hr,6hr,8hr and 24hr
Intervention2: Deodrant Aerosol Spray (B.No. 60181): sniff test
Control Intervention1: Vivel Deodrant Aeros
Sponsors
ITC RD CENTRE
Eligibility
Inclusion criteria
Inclusion criteria: Subjects in generally good health,Subjects in the age group of 18 to 50 years,Subjects without any cuts, marks and open wounds on both axillae, Subjects free of any obvious infection of skin as determined by dermatologist, Subjects with malodour score above 3, Subject has not participated in a similar investigation in the past four weeks,Subjects have not used a similar product for the last four weeks,Subjects willing to give a written informed consent and come for regular follow up.
Exclusion criteria
Exclusion criteria: Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives, hydroquinone, vitamin C, Niacin amide, retinol, soy etc.Currently or has been using topical retinoids, alpha-hydroxy and/or beta-hydroxy acids,hydroquinone or any whitening/Fairness preparation in any form (cleanser, toner, cream or soaps) within the last 1 month,Currently or has been undergoing dermatologist skin treatments or procedures within the last 1 month,Currently or has been involved in another skin care clinical investigation within the last 3 months,Subjects who have pre-existing or dormant dermatologic conditions (e.g.psoriasis, rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with the outcome of the study as determined by the investigator,Subjects with scars which could interfere with expert grader,Subjects who are nursing as determined by the investigator interview during screening or pregnant as determined by the Urine pregnancy testing after screening,Regular users of anti- malodor products /odor masking preparations or people undergoing anti- malodor therapy,Subjects habituated on a regular basis to alcohol consumption and smoking. Subjects viewed by the investigator as not being able to complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To test the efficacy of the investigational deodorant formulations in controlling or reducing the malodour in comparison to an untreated control arm up to 24 hours.Timepoint: Baseline, 2hr, 4hr, 6hr, 8hr and 24hr | — |
Secondary
| Measure | Time frame |
|---|---|
| To test the efficacy of the investigational deodorant formulations in controlling orTimepoint: Baseline, 2hr, 4hr, 6hr, 8hr and 24hr | — |
Countries
India
Contacts
Public ContactRutuja Patil
The KETs Scientific Research Centre, Cosmetology Division
Outcome results
None listed